Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: A systematic overview

John L. Petersen, Kenneth W. Mahaffey, Vic Hasselblad, Elliott M. Antman, Marc Cohen, Shaun G. Goodman, Anatoly Langer, Michael A. Blazing, Anne Le-Moigne-Amrani, James A de Lemos, Christopher C. Nessel, Robert A. Harrington, James J. Ferguson, Eugene Braunwald, Robert M. Califf